Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Heirman

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Oncotarget|October 23, 2014
Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunityKevin Van der Jeught, Patrick Tjok Joe, Lukasz Bialkowski, et al.
Journal of Leukocyte Biology|August 19, 2004
Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitizationHarmjan Kuipers, Carlo Heirman, Daniëlle Hijdra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2018
The Vacuolar Pathway of Long Peptide Cross-Presentation Can Be TAP DependentWenbin Ma, Vincent Stroobant, Carlo Heirman, et al.
Journal of Immunological Methods|January 25, 2012
Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigensAn M T Van Nuffel, Sandra Tuyaerts, Daphné Benteyn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Tumor-reactive CD4+ T cell responses to the melanoma-associated chondroitin sulphate proteoglycan in melanoma patients and healthy individuals in the absence of autoimmunityCornelia Erfurt, Zhaojun Sun, Ina Haendle, et al.
Molecular Therapy. Nucleic Acids|June 22, 2016
Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I InterferonKatrijn Broos, Kevin Van der Jeught, Janik Puttemans, et al.
Oncotarget|February 13, 2014
Immunogenicity of targeted lentivectorsCleo Goyvaerts, De Groeve Kurt, Sandra Van Lint, et al.
Oncotarget|February 16, 2015
Targeting the tumor microenvironment to enhance antitumor immune responsesKevin Van der Jeught, Lukasz Bialkowski, Lidia Daszkiewicz, et al.
Journal of Virology|July 19, 2013
Targeting of human antigen-presenting cell subsetsCleo Goyvaerts, Jozef Dingemans, Kurt De Groeve, et al.
Gastroenterology|January 4, 2003
Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cellsKarine Hellemans, Liliane Michalik, Andrea Dittie, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Oncotarget|October 23, 2014
Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunityKevin Van der Jeught, Patrick Tjok Joe, Lukasz Bialkowski, et al.
Journal of Leukocyte Biology|August 19, 2004
Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitizationHarmjan Kuipers, Carlo Heirman, Daniëlle Hijdra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2018
The Vacuolar Pathway of Long Peptide Cross-Presentation Can Be TAP DependentWenbin Ma, Vincent Stroobant, Carlo Heirman, et al.
Journal of Immunological Methods|January 25, 2012
Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigensAn M T Van Nuffel, Sandra Tuyaerts, Daphné Benteyn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Tumor-reactive CD4+ T cell responses to the melanoma-associated chondroitin sulphate proteoglycan in melanoma patients and healthy individuals in the absence of autoimmunityCornelia Erfurt, Zhaojun Sun, Ina Haendle, et al.
Molecular Therapy. Nucleic Acids|June 22, 2016
Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I InterferonKatrijn Broos, Kevin Van der Jeught, Janik Puttemans, et al.
Oncotarget|February 13, 2014
Immunogenicity of targeted lentivectorsCleo Goyvaerts, De Groeve Kurt, Sandra Van Lint, et al.
Oncotarget|February 16, 2015
Targeting the tumor microenvironment to enhance antitumor immune responsesKevin Van der Jeught, Lukasz Bialkowski, Lidia Daszkiewicz, et al.
Journal of Virology|July 19, 2013
Targeting of human antigen-presenting cell subsetsCleo Goyvaerts, Jozef Dingemans, Kurt De Groeve, et al.
Gastroenterology|January 4, 2003
Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cellsKarine Hellemans, Liliane Michalik, Andrea Dittie, et al.
Pageof 8